The SsRI/NIE Recombinant Antigen ELISA for the Follow up of Patients Infected by Strongyloides Stercoralis

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

June 6, 2023

Primary Completion Date

October 18, 2023

Study Completion Date

October 18, 2023

Conditions
Strongyloides Stercoralis Infection
Interventions
DIAGNOSTIC_TEST

InBios Strongy Detect TM IgG ELISA

The InBios Strongy Detect TM IgG ELISA detects specific IgG antibodies to Strongyloides recombinant antigens NIE and SsIR in serum. It consists of an enzymatically amplified sandwich-type immunoassay. Positive and negative control samples are provided in the kit. The test will be run and interpreted according to the manufacturer's instruction. The results are expressed as OD and nOD. Clinical interpretation of the results will be done by analysis of the Receiver Operating Characteristics (ROC) curve generated using data from confirmed positive and confirmed negative samples.

Trial Locations (1)

37024

IRCCS Sacro Cuore Don Calabria hospital, Negrar

All Listed Sponsors
lead

IRCCS Sacro Cuore Don Calabria di Negrar

OTHER

NCT06308705 - The SsRI/NIE Recombinant Antigen ELISA for the Follow up of Patients Infected by Strongyloides Stercoralis | Biotech Hunter | Biotech Hunter